Steward Partners Investment Advisory’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.8K | Hold |
2,500
| – | – | ﹤0.01% | 3661 |
|
|
2025
Q1 | $2.43K | Hold |
2,500
| – | – | ﹤0.01% | 3604 |
|
|
2024
Q4 | $2.93K | Sell |
2,500
-500
| -17% | -$585 | ﹤0.01% | 3532 |
|
|
2024
Q3 | $5.04K | Hold |
3,000
| – | – | ﹤0.01% | 3184 |
|
|
2024
Q2 | $4.26K | Hold |
3,000
| – | – | ﹤0.01% | 3098 |
|
|
2024
Q1 | $11.4K | Hold |
3,000
| – | – | ﹤0.01% | 2759 |
|
|
2023
Q4 | $8.1K | Hold |
3,000
| – | – | ﹤0.01% | 2790 |
|
|
2023
Q3 | $4.74K | Hold |
3,000
| – | – | ﹤0.01% | 2848 |
|
|
2023
Q2 | $7.88K | Hold |
3,000
| – | – | ﹤0.01% | 2648 |
|
|
2023
Q1 | $10.9K | Hold |
3,000
| – | – | ﹤0.01% | 2508 |
|
|
2022
Q4 | $11.8K | Hold |
3,000
| – | – | ﹤0.01% | 2479 |
|
|
2022
Q3 | $13K | Hold |
3,000
| – | – | ﹤0.01% | 2411 |
|
|
2022
Q2 | $14K | Hold |
3,000
| – | – | ﹤0.01% | 2377 |
|
|
2022
Q1 | $17K | Hold |
3,000
| – | – | ﹤0.01% | 2442 |
|
|
2021
Q4 | $17K | Sell |
3,000
-12,500
| -81% | -$70.8K | ﹤0.01% | 2384 |
|
|
2021
Q3 | $156K | Hold |
15,500
| – | – | ﹤0.01% | 1370 |
|
|
2021
Q2 | $136K | Hold |
15,500
| – | – | ﹤0.01% | 1861 |
|
|
2021
Q1 | $165K | Buy |
+15,500
| New | +$165K | ﹤0.01% | 1384 |
|
|
2020
Q4 | – | Sell |
-1,500
| Closed | -$8K | – | 2913 |
|
|
2020
Q3 | $8K | Buy |
+1,500
| New | +$8K | ﹤0.01% | 2212 |
|